The fibrinolytic system and obesity

Thrombosis and Haemostasis

Volumn 88, Issue 5, 2002, Pages 882-

  Lijnen, H Roger ^a   Juhan Vague, I ^a  

^a UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 2 ANTIPLASMIN; FAT; GROWTH FACTOR; LEPTIN; PLASMIN; PLASMINOGEN; PLASMINOGEN ACTIVATOR; PLASMINOGEN ACTIVATOR INHIBITOR 1;

ADIPOSE TISSUE; ANGIOGENESIS; BASEMENT MEMBRANE; BODY WEIGHT; DATA ANALYSIS; DIABETES MELLITUS; DISEASE COURSE; DRUG EFFECT; EXTRACELLULAR MATRIX; FAT INTAKE; FIBRINOLYSIS; GENE; HEMODYNAMIC PARAMETERS; LETTER; LIPID STORAGE; METABOLISM; NONHUMAN; OBESITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT STRAIN; STROMA CELL; WILD TYPE; ANIMAL; GENETICS; MOUSE; MOUSE MUTANT; NOTE; PHYSIOLOGY;

ANIMALS; FIBRINOLYSIS; MICE; MICE, KNOCKOUT; OBESITY; PLASMINOGEN; PLASMINOGEN ACTIVATOR INHIBITOR 1;

EID: 0036847648     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0037-1613324     Document Type: Letter

References (12)

1. Hoover-Plow J, Ellis J, Yuen L. In vivo plasminogen deficiency reduces fat accumulation. Thromb Haemost 2002; 87: 1011-9.
2. Juhan-Vague I, Alessi MC. Regulation of fibrinolysis in the development of atherothrombosis: Role of adipose tissue. Thromb Haemost 1999; 82: 832-6.
3. Samad F, Loskutoff DJ. Hemostatic gene expression and vascular disease in obesity: insights from studies of genetically obese mice. Thromb Haemost 1999; 82: 742-7.
4. Lijnen HR. Plasmin and matrix metalloproteinases in vascular remodeling. Thromb Haemost 2001; 86: 324-33.
5. Morange PE, Lijnen, HR, Alessi MC, Kopp F, Collen D, Juhan-Vague I. Influence of PAI-1 on adipose tissue growth and on metabolic parameters in a murine model of diet-induced obesity. Arterioscler Thromb Vasc Biol 2000; 20: 1150-4.
6. Èren M, Su M, Atkinson J, King L, Declerck P, Vaughan DE. Phenotypic derangements associated with overexpression of plasminogen activator inhibitor-1 (PAI-1) in transgenic mice. Arterioscler Thromb Vasc Biol 2001; 21: 695 (Abstr. 230).
7. Schafer K, Fujisawa K, Konstantinides S, Loskutoff J. Disruption of the plasminogen activator inhibitor 1 gene reduces the adiposity and improves the metabolic profile of genetically obese and diabetic ob/ob mice. FASEB J 2001; 15: 1840-2.
8. Morange PE, Bastelica D, Bonzi MF, Van Hoef B, Collen D, Juhan-Vague I, Lijnen HR. Influence of t-PA and u-PA on adipose tissue development in a murine model of diet-induced obesity. Thromb Haemost 2002; 87: 306-10.
9. Coleman DL. Diabetes-obesity syndromes in mice. Diabetes 1982; 31: 1-6.
10. West DB, Boozer CN, Moody DL, Atkinson RL. Dietary obesity in nine inbred mouse strains. Am J Physiol 1992; 262: R1025-R32.
11. Surwit RS, Feinglos MN, Rodin J, Sutherland A, Petro AE, Opara EC, Kuhn CM, Rebuffé-Scrive M. Differential effects of fat and sucrose on the development of obesity and diabetes in C57BL/6J and A/J mice. Metabolism 1995; 44: 645-51.
12. Valet P, Tavernier G, Castan-Laurell I, Saulnier-Blache JS, Langin D. Understanding adipose tissue development from transgenic animal models. J Lipid Res 2002; 43: 835-60.